Department of Cardiac Surgery, Fondazione IRCCS Policlinico San Matteo, Pavia, Italy.
Ann Thorac Surg. 2011 Apr;91(4):e52-3. doi: 10.1016/j.athoracsur.2010.11.019.
Ionescu-Shiley valve was withdrawn from clinical use in 1987 for its early structural failure after implantation. This was due to valve design rather than the natural properties of bovine pericardium itself. We describe the unexpected 25-year survival of an Ionescu-Shiley bioprosthesis in the mitral and tricuspid positions, implanted to treat endomyocardial fibrosis. This report makes 2 important points: (1) pannus overgrowth may be a favorable determinant of the durability of xenografts, and (2) bovine pericardial valves may have excellent hemodynamic performance and tissue durability for more than 20 years in the mitral position even in young patients.
Ionescu-Shiley 瓣膜于 1987 年因植入后的早期结构失效而退出临床应用。这是由于瓣膜设计而不是牛心包本身的天然特性所致。我们描述了 1 例 Ionescu-Shiley 生物瓣在二尖瓣和三尖瓣位置意外存活 25 年的情况,该生物瓣用于治疗心肌纤维化。本报告提出了 2 个重要观点:(1)血管翳过度生长可能是异种移植物耐久性的有利决定因素;(2)即使在年轻患者中,牛心包瓣膜在二尖瓣位置也具有超过 20 年的出色血流动力学性能和组织耐久性。